Mednet Logo

What is your approach to persistently low INR despite escalating doses of warfarin in a patient with bioprosthetic mitral valve replacement who is unable to be on DOACs?

Would it be reasonable to switch to a heparin-based product if greater than 4 weeks of subtherapeutic INR, and is there a role for VKOR testing?
2 Answers
Mednet Member
Mednet Member
Cardiology · Endeavor Health
Answered on

The assumption here is that the mitral valve is mechanical, or there are presumably other reasons that a DOAC cannot be used. If this is, in fact, a mechanical mitral valve, it would make sense to start with low molecular weight heparin injections as soon as feasible while awaiting a therapeutic INR...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Cardiology · Cardiovascular Institute At Beth Israel Deaconess Medical Center
Answered on

Depends on whether it is mechanical vs. bio prosthetic.

Join for free or sign in to see the full answer